Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cells in melanoma immunotherapy.

Mark B Faries1, Brian J Czerniecki

  • 1Department of Surgery, University of Pennsylvania, 4 Silverstein, 3400 Spruce St., Philadelphia, PA 19104, USA.

Current Treatment Options in Oncology
|May 5, 2005
PubMed
Summary

Dendritic cell vaccines show promise for melanoma treatment. Patients with advanced or adjuvant melanoma should consider investigating these investigational therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth.

Cell reports. Medicine·2026
Same author

A Cohort Study of the Effectiveness of Trastuzumab Deruxtecan for Treating Metastatic Progressive HER2-Positive Breast Cancer.

Clinical breast cancer·2026
Same author

Breaking the Immune Sanctuary: Targeting Metastatic Niches.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth.

bioRxiv : the preprint server for biology·2026
Same author

Outcomes After Intratumoral Delivery of Immunotherapy in Breast Cancer.

Journal of surgical oncology·2026
Same author

Dendritic Cell-Based Immunotherapy for Solid Tumors.

Surgical oncology clinics of North America·2026

Area of Science:

  • Oncology
  • Immunotherapy

Background:

  • Optimal systemic treatment for melanoma remains debated, particularly in adjuvant and metastatic settings.
  • Current treatment options lack universal consensus, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To explore the potential of dendritic cell (DC) vaccine therapy as a treatment strategy for melanoma.
  • To highlight the preliminary data supporting DC vaccine efficacy in melanoma patients.

Main Methods:

  • Review of investigational dendritic cell vaccine protocols for melanoma.
  • Analysis of preliminary clinical data from ongoing studies.

Main Results:

  • Dendritic cell vaccine therapy demonstrates promising preliminary results in melanoma treatment.
  • The investigational approach warrants further exploration in clinical settings.

Conclusions:

  • Dendritic cell vaccines represent a promising avenue for melanoma management.
  • Patients with metastatic or adjuvant melanoma should consider evaluating open clinical trials involving DC vaccine strategies.

Related Experiment Videos